“Retention Rate and Predictor Factors of Drug Discontinuation in Axial Spondyloarthritis: A Focus on Certolizumab and Secukinumab”. Reumatismo (June 26, 2025). Accessed June 27, 2025. https://www.reumatismo.org/reuma/article/view/1792.